22 May 2013
Keywords: cytel, mi, drug, disappoints, phase, ii, announced
Article | 10 June 1996
Cytel has announced the termination of a Phase II clinical study with
its carbohydrate-based cell adhesion blocker, Cylexin. The study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 June 1996
3 June 1996
21 May 2013
© 2013 thepharmaletter.com